InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics
NegativeFinancial Markets

InvestingPro's Fair Value model has identified a significant 43% downside potential for Apogee Therapeutics, raising concerns among investors about the company's future performance. This analysis is crucial as it highlights potential risks in the stock, prompting investors to reassess their positions and strategies in light of the findings.
— Curated by the World Pulse Now AI Editorial System